• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白吉利丝孢酵母对抗真菌药物的体外敏感性

In vitro susceptibility of Trichosporon beigelii to antifungal agents.

作者信息

Perparim K, Nagai H, Hashimoto A, Goto Y, Tashiro T, Nasu M

机构信息

Second Department of Internal Medicine, Oita Medical University, Japan.

出版信息

J Chemother. 1996 Dec;8(6):445-8. doi: 10.1179/joc.1996.8.6.445.

DOI:10.1179/joc.1996.8.6.445
PMID:8981185
Abstract

The minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFCs) of amphotericin B, flucytosine, miconazole, fluconazole and itraconazole against 21 isolates of Trichosporon beigelii in RPMI-1640 medium were determined using National Committee for Clinical Laboratory Standards (NCCLS) methodology in microdilution method. Most isolates were sensitive to miconazole (MIC90 0.78 microgram/ml), fluconazole (MIC90 6.25 micrograms/ml), and itraconazole (MIC90 0.19 microgram/ml), with the former being the most active agent tested (MFC90 3.12 mu/ml). Although amphotericin B inhibited most strains (MIC range, 0.78-3.12 micrograms/ml), poor fungicidal activity was observed (MFC range, 1.56-12.5 micrograms/ml) showing a pattern of relative resistance in vitro. Flucytosine showed generally poor activity against most isolates tested. These in vitro findings confirm the resistance of T.beigelii to amphotericin B and suggest that azoles may be an alternative to the former for the treatment of disseminated trichosporonosis. However, in vivo studies would better validate these in vitro findings.

摘要

采用美国国家临床实验室标准委员会(NCCLS)微量稀释法,在RPMI - 1640培养基中测定了两性霉素B、氟胞嘧啶、咪康唑、氟康唑和伊曲康唑对21株白吉利丝孢酵母的最低抑菌浓度(MIC)和最低杀菌浓度(MFC)。大多数分离株对咪康唑(MIC90为0.78微克/毫升)、氟康唑(MIC90为6.25微克/毫升)和伊曲康唑(MIC90为0.19微克/毫升)敏感,其中咪康唑是所测试的最具活性的药物(MFC90为3.12微克/毫升)。虽然两性霉素B抑制了大多数菌株(MIC范围为0.78 - 3.12微克/毫升),但观察到其杀菌活性较差(MFC范围为1.56 - 12.5微克/毫升),显示出体外相对耐药模式。氟胞嘧啶对大多数测试分离株的活性普遍较差。这些体外研究结果证实了白吉利丝孢酵母对两性霉素B耐药,并表明唑类药物可能是治疗播散性白吉利丝孢酵母病替代两性霉素B的药物。然而,体内研究将能更好地验证这些体外研究结果。

相似文献

1
In vitro susceptibility of Trichosporon beigelii to antifungal agents.白吉利丝孢酵母对抗真菌药物的体外敏感性
J Chemother. 1996 Dec;8(6):445-8. doi: 10.1179/joc.1996.8.6.445.
2
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].[比色肉汤微量稀释抗真菌药敏试验的多中心评估]
Rinsho Byori. 1997 Feb;45(2):190-9.
3
Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.两性霉素B和唑类药物单独及联合应用对中性粒细胞减少小鼠播散性毛孢子菌病的疗效。
Chemotherapy. 1998 Jan-Feb;44(1):55-62. doi: 10.1159/000007091.
4
Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates.NCCLS微量稀释法与Etest法对临床分离的阿萨希毛孢子菌进行抗真菌药敏试验的比较。
Diagn Microbiol Infect Dis. 2002 Jun;43(2):107-11. doi: 10.1016/s0732-8893(02)00376-0.
5
[Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].[采用肉汤微量稀释法检测临床分离白色念珠菌的抗真菌药敏性]
Kansenshogaku Zasshi. 1998 Aug;72(8):813-9. doi: 10.11150/kansenshogakuzasshi1970.72.813.
6
In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.新型三唑类药物D0870对马尔尼菲青霉菌的体外抗真菌活性与两性霉素B、氟康唑、伊曲康唑、咪康唑和氟胞嘧啶的比较。
Mycoses. 1996 Nov-Dec;39(11-12):453-6. doi: 10.1111/j.1439-0507.1996.tb00096.x.
7
Evaluation of the microdilution, Etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp.用于曲霉菌临床菌株抗真菌药敏试验的微量稀释法、Etest法和纸片扩散法的评估
J Chemother. 2005 Aug;17(4):404-8. doi: 10.1179/joc.2005.17.4.404.
8
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.氟康唑、伊曲康唑、伏立康唑、泊沙康唑和伊沙康唑对临床分离的近平滑念珠菌的抑制和杀菌活性的头对头比较。
Antimicrob Agents Chemother. 2013 Oct;57(10):4841-7. doi: 10.1128/AAC.00850-13. Epub 2013 Jul 22.
9
Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.新型隐球菌对四种抗真菌药物的抗真菌药敏试验中Etest法与微量稀释法的比较。
J Antimicrob Chemother. 2000 Dec;46(6):997-1000. doi: 10.1093/jac/46.6.997.
10
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.在体外对从塞尔维亚患者脑脊液和血液中分离的新型隐球菌的两性霉素 B、5-氟胞嘧啶、氟康唑和伊曲康唑的抗真菌活性。
J Mycol Med. 2012 Sep;22(3):243-8. doi: 10.1016/j.mycmed.2012.06.002. Epub 2012 Aug 10.

引用本文的文献

1
Genetic diversity and antifungal susceptibility testing of Trichosporon asahii isolated of Intensive Care Units patients.从重症监护病房患者中分离的近平滑假丝酵母的遗传多样性和抗真菌药敏试验。
Braz J Microbiol. 2008 Jul;39(3):585-92. doi: 10.1590/S1517-838220080003000033. Epub 2008 Sep 1.
2
Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.临床曲霉菌属对两性霉素 B、氟康唑和伏立康唑的敏感性。
Mycopathologia. 2012 Aug;174(2):121-30. doi: 10.1007/s11046-012-9525-z. Epub 2012 Feb 9.
3
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.
癌症患者中罕见的机会性(非念珠菌、非隐球菌)酵母血流感染。
J Infect. 2012 Jan;64(1):68-75. doi: 10.1016/j.jinf.2011.11.002. Epub 2011 Nov 11.
4
Current knowledge of Trichosporon spp. and Trichosporonosis. Trichosporon 属及 Trichosporonosis 的研究现状。
Clin Microbiol Rev. 2011 Oct;24(4):682-700. doi: 10.1128/CMR.00003-11.
5
Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.丝孢酵母属引起的血流感染:菌种分布、基于核糖体DNA基因间隔区1测序确定的阿萨希丝孢酵母基因型及抗真菌药敏试验
J Clin Microbiol. 2009 Apr;47(4):1074-81. doi: 10.1128/JCM.01614-08. Epub 2009 Feb 18.
6
Update on the genus Trichosporon.毛孢子菌属的最新进展。
Mycopathologia. 2008 Sep;166(3):121-32. doi: 10.1007/s11046-008-9136-x. Epub 2008 Jun 21.
7
In vitro antifungal susceptibilities of Trichosporon species.丝孢酵母属菌种的体外抗真菌药敏性
Antimicrob Agents Chemother. 2002 Apr;46(4):1144-6. doi: 10.1128/AAC.46.4.1144-1146.2002.
8
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units.三个重症监护病房非粒细胞减少患者的多重耐药阿萨希毛孢子菌感染
J Clin Microbiol. 2001 Dec;39(12):4420-5. doi: 10.1128/JCM.39.12.4420-4425.2001.